Whole exome sequencing analysis of the neoadjuvant bevacizumab plus pemetrexed and carboplatin for unresectable stage III lung adenocarcinoma: Results of the phase II GASTO 1001 trial.
2016
e20045Background: GASTO 1001 is a phase II trial investigating the efficacy and safety of induction bevacizumab plus chemotherapy followed by surgery in unresectable stage III lung adenocarcinoma. ...
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI